Global X Genomics & Biotechnology ETF
GNOM
62 hedge funds and large institutions have $107M invested in Global X Genomics & Biotechnology ETF in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 12 closing their positions.
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
13% more funds holding
Funds holding: 55 → 62 (+7)
0.25% less ownership
Funds ownership: 11.06% → 10.8% (-0.25%)
12% less capital invested
Capital invested by funds: $121M → $107M (-$14.1M)
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$3.12M |
| 2 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
+$1.87M |
| 3 |
JIP
Jaffetilchin Investment Partners
Tampa,
Florida
|
+$1.42M |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$915K |
| 5 |
BS
Banco Santander
Madrid,
Spain
|
+$754K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$2.91M |
| 2 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
-$2.06M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.67M |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.33M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.17M |
GNOM Hedge Fund Activity: Q4 2021 in Review
62 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q4 2021, worth a combined $107M — down 12% from $121M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new GNOM positions and 12 closed out — a net gain of 7 holders — while 13 added to existing stakes and 21 trimmed.
The largest buyer was Private Advisor Group, adding an estimated $3.12M. The largest seller was Mirae Asset Global Investments, cutting an estimated $2.91M.
- 62 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q4 2021, up from 55 in Q3 2021.
- Funds reported $107M of Global X Genomics & Biotechnology ETF stock for Q4 2021, down 12% quarter-over-quarter.
- 19 funds opened new Global X Genomics & Biotechnology ETF positions in Q4 2021 and 12 closed out, a net change of +7 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q4 2021 was Private Advisor Group, an estimated $3.12M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q4 2021 was Mirae Asset Global Investments, an estimated $2.91M sold.
Based on aggregated 13F filings for Q4 2021.